Related Experiment Video
Updated: Dec 19, 2025

Stereotactic Injection of MicroRNA-expressing Lentiviruses to the Mouse Hippocampus CA1 Region and Assessment of the Behavioral Outcome
Published on: June 10, 2013
Cognitive Decline and Modulation of Alzheimer's Disease-Related Genes After Inhibition of MicroRNA-101 in Mouse
C Barbato1,2, G Giacovazzo3, F Albiero4
1Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Campus A. Buzzati-Traverso, via E. Ramarini 32, Monterotondo, RM, Italy.
Abstract:
MicroRNAs have emerged as regulators of brain development and function. Reduction of miR-101 expression has been reported in rodent hippocampus during ageing, in the brain of Alzheimer's disease (AD) patients and in AD animal models. In this study, we investigated the behavioral and molecular consequences of inhibition of endogenous miR-101 in 4-5-month-old C57BL/6J mice, infused with lentiviral particles expressing a miR-101 sponge (pLSyn-miR-101 sponge) in the CA1 field of the hippocampus. The sponge-infected mouse model showed cognitive impairment. The pLSyn-miR-101 sponge-infected mice were unable to discriminate either a novel object location or a novel object as assessed by object place recognition (OPR) and novel object recognition (NOR) tasks, respectively. Moreover, the sponge-infected mice evaluated for contextual memory in inhibitory avoidance task showed shorter retention latency compared to control pLSyn mice. These cognitive impairment features were associated with increased hippocampal expression of relevant miR-101 target genes, amyloid precursor protein (APP), RanBP9 and Rab5 and overproduction of amyloid beta (Aβ) 42 levels, the more toxic species of Aβ peptide. Notably, phosphorylation-dependent AMP-activated protein kinase (AMPK) hyperactivation is associated with AD pathology and age-dependent memory decline, and we found AMPK hyperphosphorylation in the hippocampus of pLSyn-miR-101 sponge mice. This study demonstrates that mimicking age-associated loss of miR-101 in hippocampal neurons induces cognitive decline and modulation of AD-related genes in mice.
Insights
Loss of microRNA-101 in the hippocampus impairs memory and increases Alzheimer's disease (AD) markers. Mimicking this loss in mice induced cognitive deficits and AD-related gene changes, highlighting miR-101's role in brain aging and AD.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs regulate brain development and function.
- Reduced miR-101 expression is linked to aging, Alzheimer's disease (AD), and AD models.
- Endogenous miR-101 inhibition's effects in the hippocampus are not fully understood.
Purpose of the Study:
- To investigate the behavioral and molecular consequences of inhibiting miR-101 in the mouse hippocampus.
- To determine if reduced miR-101 contributes to cognitive impairment and AD pathology.
Main Methods:
- Used lentiviral particles expressing a miR-101 sponge in the CA1 hippocampus of C57BL/6J mice.
- Assessed cognitive function using object place recognition (OPR), novel object recognition (NOR), and inhibitory avoidance tasks.
- Analyzed hippocampal gene expression of miR-101 targets (APP, RanBP9, Rab5), amyloid beta (Aβ) 42 levels, and AMP-activated protein kinase (AMPK) phosphorylation.
Main Results:
- Mice with inhibited miR-101 exhibited significant cognitive impairment in OPR, NOR, and inhibitory avoidance tasks.
- Hippocampal expression of miR-101 target genes (APP, RanBP9, Rab5) and Aβ42 levels were increased.
- Hyperphosphorylation of AMPK was observed in the hippocampus of these mice.
Conclusions:
- Mimicking age-associated miR-101 loss in hippocampal neurons induces cognitive decline in mice.
- Inhibition of miR-101 modulates AD-related genes and contributes to AD pathology.
- miR-101 plays a crucial role in maintaining cognitive function and preventing AD-like changes in the hippocampus.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment

